A Win For Tonix Pharmaceuticals Holding Corp.
Wed, Jun 01, 2022 at 05:30 PM
Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ) rocketted at $3.15, representing a gain of 29.1%. On Tue, May 31, 2022, TNXP:NASDAQ touched a New 2-Week Intraday High of $2.55. The stock got featured on our News Catalysts scanner on Wed, Jun 01, 2022 at 10:27 AM in the 'BIOTECH' category. From Tue, May 17, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Mon, May 23, 2022 at $2.93 with a volume of 20M+.
About Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ)
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.
Top 10 Gainers:
- Missfresh Limited (MF:NASDAQ), 51.05%
- Spark Networks SE (LOV:NASDAQ), 38.39%
- Energy Focus, Inc. (EFOI:NASDAQ), 37.42%
- View Inc. (VIEW:NASDAQ), 33.07%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 31.48%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 30.62%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 29.1%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 25.58%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.23%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 19.76%